diabetic nephropathy stage ?
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient with a clear history of type 2 diabetes; 2. Meet the diagnostic criteria for type 2 DN,diabetic nephropathy stage III; 3. Aged 18 to 70 years; 4. In line with kidney yin deficiency syndrome or yang deficiency syndrome or yin and yang deficiency syndrome; 5. Subjects must be informed details of the trail and sign the informed consent; 6. Patients can provide detailed contact information, no short-term migration, willing to follow-up.
Exclusion criteria
Exclusion criteria: 1. Other primary diseases (chronic nephritis, hypertension, gout, lupus erythematosus, etc.) increased urinary albumin excretion rate; 2. Renal Vascular Hypertension; 3. Over the past six months there have been malignant hypertension, myocardial infarction, cerebrovascular accident, diabetic ketoacidosis and other critically illness; 4. With congestive heart failure?-? level; 5. The recent time(4 weeks) with severe infection; 6. Combined with heart, liver, brain, kidney and hematopoietic system and other serious primary disease, cancer, mental patients; 7. Pregnancy or preparation of pregnancy, breast-feeding women; 8. Known to the class of drug allergy and severe allergies; 9. Nearly 3 months to participate in other clinical trials of drug patients; 10. Those who do not fully understand this study, do not want to participate, or poor compliance,uncooperative (not with diet control, or do not follow the provisions of the efficacy of medication to determine the impact will be excude.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of end events; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood glucose;glycosylated hemoglobin;ACR;SCr;blood pressure;BMI;Lipids; | — |
Countries
China
Contacts
Beijing Shijitan Hospital, Capital Medical University